دانلود کتاب درسی مدیریت بالینی داروهای باشگاهی و مواد جدید روانگردان

This document provides a new edition and an update to the 2015 NEPTUNE guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of ‘club drugs’ and ‘novel psychoactive substances’ (NPS). The guidance is evidence-based and is a response to the gap in knowledge and experience in themanagement of these drugs. There is evidence that clinicians often feel poorly equipped to assess and manage the harms of NPS and report that more education on emerging drugs and misuse patterns is needed.1 It has also been noted that continued education on NPS is fundamental for the provision of improved harm reduction services, which can enhance overall care for NPS service users.2 Patterns of drug use continue to be dynamic. At the time of publication of this second edition, the quantity and range of drugs available to people is wider than ever. Recreational users typically use a wide repertoire of substances: • ‘Traditional’ drugs continue to be the most used (depending on country, but e.g. cannabis, cocaine, amphetamines). • Novel psychoactive substances (NPS) are used along with these traditional drugs, but have not replaced them. • Increase of non-medical use of prescription drugs. This document focuses on the health-related harms of club drugs and NPS and their clinical management. The use of substances referred to as ‘club drugs’ has been well established for many decades. It includes illicit substances, e.g. cocaine and amphetamine, as well as NPS.